Catherine Verfaillie

Catherine Verfaillie is trained as an MD, hematologist at the KULeuven, and went to the University of Minnesota in 1987 for a postdoctoral fellowship, where she became a full Professor of Medicine in 1998 and became the first Director of the University of Minnesota’s Stem Cell Institute in 1999. In 2006 she accepted to become the director of the Interdepartmental Stem Cell Institute at the KULeuven. She has a longstanding career in stem cell biology, initially focusing on normal hematopoietic stem cells and leukemic stem cells. Since 2000 she has also focused extensively on more pluripotent stem cells, when she described stem cells from postnatal origin with greater potency, named multipotent adult progenitor cells or MAPC. The interest of the Verfaillie lab in Leuven is currently focused on understanding what regulates selfrenewal and differentiation of hematopoietic and adult as well as embryonic pluripotent stem cell, and testing the possible use of stem cell based and stem cell derived therapies in animal models of hematopoietic, vascular, liver and metabolic (diabetes) disorders.

Share |